Dorman Products (NASDAQ: DORM) reported Q2 EPS of $2.06, $0.21 better than the analyst estimate of $1.85. Revenue for the quarter came in at $541 million versus the consensus estimate of $525.03 million.

GUIDANCE:

Dorman Products sees FY2025 EPS of $8.60-$8.90, versus the consensus of $7.85.

For earnings history and earnings-related data on Dorman Products (DORM) click here.